Use of Radioisotopes in the Study of Shoulder to Thigh Circulation Time

1971 ◽  
Vol 10 (04) ◽  
pp. 316-324
Author(s):  
Vernon Ficken ◽  
Carl Smith ◽  
Samuel Halpern

SummaryA method is described for the measurement of shoulder to thigh circulation times using isotopic methodology. Following the positioning of scintillation probes over the subclavian vein at the shoulder and the femoral artery at the level of the inguinal ligament, one millicurie of 99mTcO4 – is injected as a bolus into the arm distal to the shoulder probe. The time between arrival of the radionuclide at the shoulder and femoral artery is the circulation time. The method is accurate and reproducible. Normal circulation times averaged 13.7 ± 2.8 seconds. Patients with congestive heart failure averaged 32 seconds with a range of 19.6—15.6. Hyperthyroid patients averaged 9.1 seconds with a range of 6.2— 13.8. Following treatment the hyperthyroid patients who became euthyroid generally developed normal circulation times while those that remained hyperthyroid continued to have shortened circulation times. The method for doing the circulation time described is useful since it is completely objective, non toxic, may be used in studying the comatose patient, and gives a written record for incorporation into the patient’s clinical chart.

2003 ◽  
Vol 285 (4) ◽  
pp. H1576-H1581 ◽  
Author(s):  
Fraser D. Russell ◽  
Deborah Meyers ◽  
Andrew J. Galbraith ◽  
Nick Bett ◽  
Istvan Toth ◽  
...  

Human urotensin-II (hU-II) is the most potent endogenous cardiostimulant identified to date. We therefore determined whether hU-II has a possible pathological role by investigating its levels in patients with congestive heart failure (CHF). Blood samples were obtained from the aortic root, femoral artery, femoral vein, and pulmonary artery from CHF patients undergoing cardiac catheterization and the aortic root from patients undergoing investigative angiography for chest pain who were not in heart failure. Immunoreactive hU-II (hU-II-ir) levels were determined with radioimmunoassay. hU-II-ir was elevated in the aortic root of CHF patients (230.9 ± 68.7 pg/ml, n = 21; P < 0.001) vs. patients with nonfailing hearts (22.7 ± 6.1 pg/ml, n = 18). This increase was attributed to cardiopulmonary production of hU-II-ir because levels were lower in the pulmonary artery (38.2 ± 6.1 pg/ml, n = 21; P < 0.001) than in the aortic root. hU-II-ir was elevated in the aortic root of CHF patients with nonischemic cardiomyopathy (142.1 ± 51.5 pg/ml, n = 10; P < 0.05) vs. patients with nonfailing hearts without coronary artery disease (27.3 ± 12.4 pg/ml, n = 7) and CHF patients with ischemic cardiomyopathy (311.6 ± 120.4 pg/ml, n = 11; P < 0.001) vs. patients with nonfailing hearts and coronary artery disease (19.8 ± 6.6 pg/ml, n = 11). hU-II-ir was significantly higher in the aortic root than in the pulmonary artery and femoral vein, with a nonsignificant trend for higher levels in the aortic root than in the femoral artery. The findings indicated that hU-II-ir is elevated in the aortic root of CHF patients and that hU-II-ir is cleared at least in part from the microcirculation.


Circulation ◽  
1955 ◽  
Vol 11 (6) ◽  
pp. 900-908 ◽  
Author(s):  
PAUL STUCKI ◽  
J. D. HATCHER ◽  
WALTER E. JUDSON ◽  
ROBERT W. WILKINS

2000 ◽  
Vol 21 (3) ◽  
pp. 269-270 ◽  
Author(s):  
R. Dogan ◽  
M. Yılmaz ◽  
S. Özkutlu ◽  
H. Elsharshari

Sign in / Sign up

Export Citation Format

Share Document